Development of Antiarrhythmic Therapy-Resistant Ventricular Tachycardia, Ventricular Fibrillation, and Premature Ventricular Contractions in a 15-Year-Old Patient
- PMID: 35178281
- PMCID: PMC8843404
- DOI: 10.1055/s-0040-1715851
Development of Antiarrhythmic Therapy-Resistant Ventricular Tachycardia, Ventricular Fibrillation, and Premature Ventricular Contractions in a 15-Year-Old Patient
Abstract
Sudden cardiac arrest (SCA) is the sudden cessation of regular cardiac activity so that the victim becomes unresponsive, with no signs of circulation and no normal breathing. Asystole, ventricular tachycardia (VT), ventricular fibrillation (VF), and pulseless electrical activity are the underlying rhythm disturbances in the pediatric age group. If appropriate interventions (cardiopulmonary resuscitation-CPR and/or defibrillation or cardioversion) are not performed rapidly, this condition progresses to sudden death. There have not been many reported cases of the approach and treatment of cardiac arrhythmias after SCA. Herein, we would like to report a case of a 15-year-old female patient with dilated cardiomyopathy (DCM) who was admitted to our clinic a year ago, and while her left ventricular systolic functions were improved, SCA suddenly occurred. Since the SCA event occurred in another city, intravenous treatment of amiodarone was done immediately and was switch to continuous infusion dose of amiodarone until the patient arrived at our institution's pediatric intensive care unit (PICU) 3 hours later. During the patient's 20-day PICU hospitalization, she developed pulseless VT and VF from time to time. The patient's pulseless VT and VF attacks were brought under control by the use of a defibrillator and added antiarrhythmic drugs (amiodarone, flecainide, esmolol, and propafenone). Intriguingly, therapy-resistance bigeminy with premature ventricular contractions (PVCs) continued despite all these treatments. The patient did not have adequate blood pressure measured by invasive arterial blood pressure monitoring while having bigeminy PVCs. The intermittent bigeminy PVCs ameliorated rapidly after intermittent boluses of lidocaine. In the end, multiple antiarrhythmic therapies and intermittent bolus lidocaine doses were enough to bring her cardiac arrhythmias after SCA under control. This case illustrates that malign PVC's should be taken very seriously, since they may predispose to the development of VT or VF. Also, this case highlights the importance of close vigilance of arterial pressure tracings of patients with bigeminy PVCs which develop after SCA and should not be accepted as normal.
Keywords: bigeminy premature ventricular contractions; lidocaine; pediatric intensive care unit; ventricular fibrillation; ventricular tachycardia.
Thieme. All rights reserved.
Conflict of interest statement
Conflict of Interest None declared.
Figures
Similar articles
-
Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo).Circulation. 2017 Nov 28;136(22):2119-2131. doi: 10.1161/CIRCULATIONAHA.117.028624. Epub 2017 Sep 13. Circulation. 2017. PMID: 28904070 Free PMC article. Clinical Trial.
-
Arrhythmias in the intensive care patient.Curr Opin Crit Care. 2003 Oct;9(5):345-55. doi: 10.1097/00075198-200310000-00003. Curr Opin Crit Care. 2003. PMID: 14508146 Review.
-
Association of initial recorded rhythm and underlying cardiac disease in sudden cardiac arrest.Resuscitation. 2018 Jan;122:76-78. doi: 10.1016/j.resuscitation.2017.11.064. Epub 2017 Nov 27. Resuscitation. 2018. PMID: 29191702
-
Successful management of ventricular fibrillation and ventricular tachycardia using defibrillation and intravenous amiodarone therapy in a cat.J Vet Emerg Crit Care (San Antonio). 2020 Jul;30(4):474-480. doi: 10.1111/vec.12960. Epub 2020 May 13. J Vet Emerg Crit Care (San Antonio). 2020. PMID: 32400960
-
Antiarrhythmic drug therapy during cardiopulmonary resuscitation: should we use it?Curr Opin Crit Care. 2018 Jun;24(3):138-142. doi: 10.1097/MCC.0000000000000498. Curr Opin Crit Care. 2018. PMID: 29561289 Review.
Cited by
-
Effects of Amiodarone and Esmolol for Heart Rate and Cardiovascular Changes.Emerg Med Int. 2022 Jun 27;2022:9197369. doi: 10.1155/2022/9197369. eCollection 2022. Emerg Med Int. 2022. Retraction in: Emerg Med Int. 2023 Aug 9;2023:9789785. doi: 10.1155/2023/9789785. PMID: 35794904 Free PMC article. Retracted.
References
-
- Buxton A E, Calkins H, Callans D J. ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology) Circulation. 2006;114(23):2534–2570. - PubMed
-
- Thiene G. Sudden cardiac death and cardiovascular pathology: from anatomic theater to double helix. Am J Cardiol. 2014;114(12):1930–1936. - PubMed
-
- Pelliccia A, Solberg E E, Papadakis M. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC) Eur Heart J. 2019;40(01):19–33. - PubMed
Publication types
LinkOut - more resources
Full Text Sources